Document Detail


Etanercept-related extensive pulmonary nodulosis in a patient with rheumatoid arthritis.
MedLine Citation:
PMID:  17610313     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: Although nodulosis is a common extraarticular manifestation of rheumatoid arthritis, accelerated pulmonary nodulosis is a rare event. The etiology of rheumatoid nodules is still unknown. Nodulosis is not necessarily associated with active joint inflammation, suggesting different pathogenic mechanisms for nodule formation and synovial tissue inflammation. We describe a patient with extensive pulmonary nodulosis, probably related to etanercept treatment. Our case emphasizes the need for careful monitoring for adverse events during treatment with biologicals, especially since the differential diagnosis often includes a broad spectrum of diseases.
Authors:
Annelies van Ede; Alfons den Broeder; Michiel Wagenaar; Piet van Riel; Marjonne C W Creemers
Related Documents :
10767933 - Non-cardiogenic pulmonary oedema due to foreign body aspiration.
2295243 - Pulmonary infiltrates associated with sulindac therapy.
8197973 - Color doppler study of mitral regurgitation during percutaneous transluminal coronary a...
Publication Detail:
Type:  Case Reports; Journal Article     Date:  2007-06-15
Journal Detail:
Title:  The Journal of rheumatology     Volume:  34     ISSN:  0315-162X     ISO Abbreviation:  J. Rheumatol.     Publication Date:  2007 Jul 
Date Detail:
Created Date:  2007-07-05     Completed Date:  2007-08-16     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7501984     Medline TA:  J Rheumatol     Country:  Canada    
Other Details:
Languages:  eng     Pagination:  1590-2     Citation Subset:  IM    
Affiliation:
Department of Rheumatology, University Medical Centre Nijmegen, Nijmegen, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anti-Inflammatory Agents / therapeutic use
Antirheumatic Agents / adverse effects*
Arthritis, Rheumatoid*
Azathioprine / therapeutic use
Drug Therapy, Combination
Humans
Immunoglobulin G / adverse effects*
Immunosuppressive Agents / therapeutic use
Male
Middle Aged
Prednisone
Radiography, Thoracic
Receptors, Tumor Necrosis Factor
Rheumatoid Nodule / chemically induced*,  drug therapy,  pathology
Tomography, X-Ray Computed
Withholding Treatment
Chemical
Reg. No./Substance:
0/Anti-Inflammatory Agents; 0/Antirheumatic Agents; 0/Immunoglobulin G; 0/Immunosuppressive Agents; 0/Receptors, Tumor Necrosis Factor; 185243-69-0/TNFR-Fc fusion protein; 446-86-6/Azathioprine; 53-03-2/Prednisone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Systematic review of accuracy of fetal urine analysis to predict poor postnatal renal function in ca...
Next Document:  Association of drug transporter gene ABCB1 (MDR1) 3435C to T polymorphism with colchicine response i...